SI1804804T1 - 3-(4-(DIBENZO(b,f)(1,4)OKSAZEPIN-11-IL)PIPERAZIN-1-IL)2,2-DIMETIL PROPANOJSKA KISLINA ZA UPORABO PRI ZDRAVLJENJU MOTENJ SPANJA - Google Patents

3-(4-(DIBENZO(b,f)(1,4)OKSAZEPIN-11-IL)PIPERAZIN-1-IL)2,2-DIMETIL PROPANOJSKA KISLINA ZA UPORABO PRI ZDRAVLJENJU MOTENJ SPANJA

Info

Publication number
SI1804804T1
SI1804804T1 SI200531483T SI200531483T SI1804804T1 SI 1804804 T1 SI1804804 T1 SI 1804804T1 SI 200531483 T SI200531483 T SI 200531483T SI 200531483 T SI200531483 T SI 200531483T SI 1804804 T1 SI1804804 T1 SI 1804804T1
Authority
SI
Slovenia
Prior art keywords
åoxazepin
dibenzo
piperazin
treatment
propanoic acid
Prior art date
Application number
SI200531483T
Other languages
English (en)
Inventor
Dale M Edgar
David G Hangauer
Kazumi Shiosaki
Michael Solomon
James F White
Original Assignee
Hypnion Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hypnion Inc filed Critical Hypnion Inc
Priority claimed from PCT/US2005/034015 external-priority patent/WO2006034414A2/en
Publication of SI1804804T1 publication Critical patent/SI1804804T1/sl

Links

SI200531483T 2004-09-21 2005-09-21 3-(4-(DIBENZO(b,f)(1,4)OKSAZEPIN-11-IL)PIPERAZIN-1-IL)2,2-DIMETIL PROPANOJSKA KISLINA ZA UPORABO PRI ZDRAVLJENJU MOTENJ SPANJA SI1804804T1 (sl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US61184904P 2004-09-21 2004-09-21
US67319805P 2005-04-19 2005-04-19
PCT/US2005/034015 WO2006034414A2 (en) 2004-09-21 2005-09-21 Loxapine analogs and methods of use thereof
EP05801120A EP1804804B1 (en) 2004-09-21 2005-09-21 3-[4-(DIBENZO[b,f][1,4]OXAZEPIN-11-YL)-PIPERAZIN-1-YL]-2,2-DIMETHYL PROPANOIC ACID FOR USE IN THE TREATMENT OF SLEEP DISORDERS

Publications (1)

Publication Number Publication Date
SI1804804T1 true SI1804804T1 (sl) 2012-04-30

Family

ID=38866598

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200531483T SI1804804T1 (sl) 2004-09-21 2005-09-21 3-(4-(DIBENZO(b,f)(1,4)OKSAZEPIN-11-IL)PIPERAZIN-1-IL)2,2-DIMETIL PROPANOJSKA KISLINA ZA UPORABO PRI ZDRAVLJENJU MOTENJ SPANJA

Country Status (4)

Country Link
CN (1) CN101060847B (sl)
SI (1) SI1804804T1 (sl)
UA (1) UA86265C2 (sl)
ZA (1) ZA200702334B (sl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4428132A1 (en) * 2023-03-08 2024-09-11 Johann-Wolfgang-Goethe-Universität Frankfurt am Main Slack-activating compounds and their medical use
WO2024184543A1 (en) * 2023-03-08 2024-09-12 Johann Wolfgang Goethe-Universität Frankfurt am Main Slack-activating compounds and their medical use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR199801800T2 (xx) * 1996-03-11 1998-12-21 Eli Lilly And Company Uykusuzluk tedavisi.
BR0317528A (pt) * 2002-12-20 2005-11-22 Basf Ag Uso dos compostos, métodos para o controle de insetos, aracnìdeos ou nematodos, e para a proteção de plantas em crescimento contra o ataque ou a infestação por insetos, aracnìdeos ou nematodos, compostos, e, composições
CN100402036C (zh) * 2004-04-26 2008-07-16 袁重华 治疗失眠的涂敷剂

Also Published As

Publication number Publication date
UA86265C2 (uk) 2009-04-10
CN101060847A (zh) 2007-10-24
ZA200702334B (en) 2008-09-25
CN101060847B (zh) 2010-05-05

Similar Documents

Publication Publication Date Title
PL1804804T3 (pl) Kwas 3-[4-dibenzo[b,f][1,4]oksazepin-11-ylo)piperazyn-1-ylo]-2,2-dimetylopropionowy do zastosowania w leczeniu zaburzeń snu
EP1601251A4 (en) COMPOUNDS FOR THE TREATMENT OF TABOLIC M DISORDERS
EP1940373B8 (en) 1-fluoro-1-deoxy-scyllo-inositol for the treatment of alzheimer's disease
IL209842A0 (en) Compounds for the treatment of metabolic disorders
PL1611091T3 (pl) Podstawione pochodne kwasów fenyloalkanowych i ich zastosowanie do leczenia chorób układu oddechowego
ZA200803440B (en) Compounds for the treatment of metabolic disorders
IL187168A0 (en) Improved nanobodiestm for the treatment of aggregation-mediated disorders
HK1091732A1 (en) Use of modified cyclosporins for the treatment of hcv disorders
ZA200608628B (en) Substituted morpholine compounds for the treatment of central nervous system disorders
ZA200606834B (en) 1-Aminocyclohexane derivatives for the treatment of agitation and other behavioral disorders, especially those associated with Alzheimer's disease
HK1051504A1 (en) Use of compounds with 5-ht1a activity useful for treating disorders of the outer retina
HK1100481A1 (en) Use of agomelatine in obtaining medicaments intended for the treatment of sleep disorders in the depressed patient
AU2003286728A8 (en) Compounds for the treatment of metabolic disorders
EP1876900A4 (en) PHOSPHOINOSITIDE MODULATION FOR TREATING ALZHEIMER'S DISEASE
AU2003299715A8 (en) Compounds for the normalization of the sleep/wake cycle
EP1581206A4 (en) TREATMENT OF INFLAMMATORY DISEASES WITH 2,3-BENZODIAZEPINES
HK1074402A1 (en) Use of amide derivative of ge 2270 factor a3 for the treatment of acne
EP1898921A4 (en) COMPOSITIONS AND METHODS FOR TREATING SLEEP DISORDERS
SI1804804T1 (sl) 3-(4-(DIBENZO(b,f)(1,4)OKSAZEPIN-11-IL)PIPERAZIN-1-IL)2,2-DIMETIL PROPANOJSKA KISLINA ZA UPORABO PRI ZDRAVLJENJU MOTENJ SPANJA
NO20023803D0 (no) Anvendelse av mirtazapin for behandling av sövnforstyrrelser
AU2003294100A8 (en) Use of hyaluronic acid for respiratory disorders or the upper airways
TWI318115B (en) Use of agomelatine in obtaining medicaments intended for the treatment of bipolar disorders
EP1869004A4 (en) SUBSTITUTED CARBOXYLIC ACID DERIVATIVES FOR THE TREATMENT OF DIABETES AND LIPID DISORDERS, THEIR SYNTHESIS AND THEIR APPLICATIONS
HRP20041160A2 (en) Novel combination for the treatment of airway disorders
TWI340643B (en) 1-[2h-1-benzopyran-2-one-8-yl]-piperazine derivatives for the treatment of movement disorders